Cellyan Biotechnology Co., Ltd (HKPD) stock
HKPDNasdaqWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends March 31
$1.52−0.09 (-5.30%)
Close on Nov 17, 2026Market cap $24.93MP/E –Yield –
Cellyan Biotechnology price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Cellyan Biotechnology's price to book ratio was 2.8× on Nov 11, 2026, against 39.2× a year earlier.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 2.8× | +1.1 |
| 2025 | Dec 31, 2025 | 1.6× | – |
See a number that looks wrong?